0.46
price up icon3.51%   0.0156
after-market Handel nachbörslich: .46
loading
Schlusskurs vom Vortag:
$0.4444
Offen:
$0.4499
24-Stunden-Volumen:
1.42M
Relative Volume:
0.47
Marktkapitalisierung:
$74.83M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-111.13M
KGV:
-0.3485
EPS:
-1.32
Netto-Cashflow:
$-91.53M
1W Leistung:
+6.88%
1M Leistung:
-4.76%
6M Leistung:
-87.11%
1J Leistung:
-89.00%
1-Tages-Spanne:
Value
$0.431
$0.46
1-Wochen-Bereich:
Value
$0.4253
$0.4759
52-Wochen-Spanne:
Value
$0.36
$4.29

Tenaya Therapeutics Inc Stock (TNYA) Company Profile

Name
Firmenname
Tenaya Therapeutics Inc
Name
Telefon
415-865-2066
Name
Adresse
171 OYSTER POINT BLVD., SUITE 500, SOUTH SAN FRANCISCO
Name
Mitarbeiter
97
Name
Twitter
Name
Nächster Verdiensttermin
Name
Neueste SEC-Einreichungen
Name
TNYA's Discussions on Twitter

Vergleichen Sie TNYA mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
TNYA
Tenaya Therapeutics Inc
0.46 70.01M 0 -111.13M -91.53M -1.32
Biotechnology icon
ONC
Beone Medicines Ltd Adr
245.58 26.10B 3.81B -644.79M -669.77M -6.24
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
442.05 111.96B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
AKTX
Akari Therapeutics Plc Adr
1.35 42.96M 0 0 0 0.00
Biotechnology icon
VRNA
Verona Pharma Plc Adr
81.20 6.39B 0 -153.72M -103.81M -2.00
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
490.28 63.52B 14.09B 4.50B 2.96B 39.28

Tenaya Therapeutics Inc Stock (TNYA) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2024-06-10 Eingeleitet William Blair Outperform
2023-11-30 Eingeleitet Leerink Partners Outperform
2022-06-15 Eingeleitet H.C. Wainwright Buy

Tenaya Therapeutics Inc Aktie (TNYA) Neueste Nachrichten

pulisher
May 31, 2025

Northern Trust Corp Grows Stock Holdings in Tenaya Therapeutics, Inc. (NASDAQ:TNYA) - Defense World

May 31, 2025
pulisher
May 30, 2025

Tenaya Therapeutics Appoints New Directors at Annual Meeting - TipRanks

May 30, 2025
pulisher
May 21, 2025

Tenaya Therapeutics, Inc. (NASDAQ:TNYA) Receives $6.25 Average Target Price from Brokerages - Defense World

May 21, 2025
pulisher
May 18, 2025

Price T Rowe Associates Inc. MD Sells 2,892,201 Shares of Tenaya Therapeutics, Inc. (NASDAQ:TNYA) - Defense World

May 18, 2025
pulisher
May 17, 2025

Tenaya therapeutics SVP Higa Tomohiro sells $615 in stock By Investing.com - Investing.com Nigeria

May 17, 2025
pulisher
May 16, 2025

Tenaya Therapeutics chief medical officer sells $1,300 in stock By Investing.com - Investing.com Nigeria

May 16, 2025
pulisher
May 16, 2025

Tenaya Therapeutics chief medical officer sells $1,300 in stock - Investing.com Australia

May 16, 2025
pulisher
May 16, 2025

Tenaya therapeutics SVP Higa Tomohiro sells $615 in stock - Investing.com

May 16, 2025
pulisher
May 15, 2025

Tenaya Therapeutics Awards Major Stock Options Package: 461K Shares for Strategic New Hires - Stock Titan

May 15, 2025
pulisher
May 15, 2025

Tenaya Therapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4) - GlobeNewswire

May 15, 2025
pulisher
May 15, 2025

Greenlane Renewables Announces First Quarter 2025 Financial Results - The Globe and Mail

May 15, 2025
pulisher
May 15, 2025

Barclays PLC Sells 184,837 Shares of Tenaya Therapeutics, Inc. (NASDAQ:TNYA) - Defense World

May 15, 2025
pulisher
May 13, 2025

Tenaya Therapeutics (TNYA) to Showcase Key Research at ASGCT 2025 | TNYA Stock News - GuruFocus

May 13, 2025
pulisher
May 13, 2025

Tenaya Therapeutics to Highlight Capsid Engineering, Gene Editing and Manufacturing Research at the ASGCT 28th Annual Meeting - The Manila Times

May 13, 2025
pulisher
May 13, 2025

Tenaya Therapeutics to Present Five Abstracts on Innovative Heart Disease Gene Therapies at ASGCT 2025 Annual Meeting - Nasdaq

May 13, 2025
pulisher
May 13, 2025

Tenaya Therapeutics to Highlight Capsid Engineering, Gene - GlobeNewswire

May 13, 2025
pulisher
May 13, 2025

Hsbc Holdings PLC Purchases New Position in Tenaya Therapeutics, Inc. (NASDAQ:TNYA) - Defense World

May 13, 2025
pulisher
May 12, 2025

Leerink Partnrs Issues Positive Forecast for TNYA Earnings - Defense World

May 12, 2025
pulisher
May 12, 2025

Tenaya Therapeutics’ (TNYA) Buy Rating Reiterated at Chardan Capital - Defense World

May 12, 2025
pulisher
May 12, 2025

Equities Analysts Issue Forecasts for TNYA Q2 Earnings - Defense World

May 12, 2025
pulisher
May 10, 2025

We're A Little Worried About Tenaya Therapeutics' (NASDAQ:TNYA) Cash Burn Rate - Yahoo Finance

May 10, 2025
pulisher
May 09, 2025

Chardan Capital Maintains Buy Rating for Tenaya Therapeutics (TNYA) | TNYA Stock News - GuruFocus

May 09, 2025
pulisher
May 08, 2025

Tenaya Therapeutics Reports Q1 2025 Financial Results - TipRanks

May 08, 2025
pulisher
May 07, 2025

Tenaya (TNYA) Reports Promising Clinical Trial Developments and Financial Outlook | TNYA Stock News - GuruFocus

May 07, 2025
pulisher
May 07, 2025

Tenaya Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update - GlobeNewswire

May 07, 2025
pulisher
May 02, 2025

A Cautious Investment in the Drone Sector - The Globe and Mail

May 02, 2025
pulisher
Apr 30, 2025

Geode Capital Management LLC Sells 27,419 Shares of Tenaya Therapeutics, Inc. (NASDAQ:TNYA) - Defense World

Apr 30, 2025
pulisher
Apr 28, 2025

Layoff Tracker: Ono Cuts 83 Employees in Massachusetts - BioSpace

Apr 28, 2025
pulisher
Apr 25, 2025

H.C. Wainwright maintains Buy on Tenaya Therapeutics stock By Investing.com - Investing.com South Africa

Apr 25, 2025
pulisher
Apr 25, 2025

H.C. Wainwright maintains Buy on Tenaya Therapeutics stock - Investing.com Australia

Apr 25, 2025
pulisher
Apr 24, 2025

TNYATenaya Therapeutics, Inc. Latest Stock News & Market Updates - Stock Titan

Apr 24, 2025
pulisher
Apr 24, 2025

Tenaya reports progress in ARVC gene therapy study - Investing.com

Apr 24, 2025
pulisher
Apr 24, 2025

Tenaya Therapeutics Presents Interim Data from RIDGE™ Natural History and Seroprevalence Study of Adults with PKP2-associated ARVC at Heart Rhythm 2025 - The Manila Times

Apr 24, 2025
pulisher
Apr 24, 2025

Tenaya Therapeutics Presents Interim Data from RIDGE™ - GlobeNewswire

Apr 24, 2025
pulisher
Apr 24, 2025

Major Breakthrough: 175-Patient ARVC Study Shows 93% Could Benefit from New Gene Therapy Treatment - Stock Titan

Apr 24, 2025
pulisher
Apr 21, 2025

Strategy (MSTR) Buys Another $556 Million Worth of Bitcoin - The Globe and Mail

Apr 21, 2025
pulisher
Apr 19, 2025

Tenaya Therapeutics faces Nasdaq delisting over share price By Investing.com - Investing.com India

Apr 19, 2025
pulisher
Apr 18, 2025

Tenaya Therapeutics faces Nasdaq delisting over share price - Investing.com Australia

Apr 18, 2025
pulisher
Apr 11, 2025

Alignment Healthcare to Announce First Quarter 2025 Financial Results and Host Conference Call Thursday, May 1, 2025 - The Globe and Mail

Apr 11, 2025
pulisher
Apr 04, 2025

Leerink Partnrs Issues Optimistic Forecast for TNYA Earnings - Defense World

Apr 04, 2025
pulisher
Apr 03, 2025

Finance Watch: As Stocks Tumble, Offerings Slow, Financial Alternatives Rise - insights.citeline.com

Apr 03, 2025
pulisher
Apr 01, 2025

Tenaya highlights HCM gene therapy interim data at ACC 2025 - Yahoo

Apr 01, 2025
pulisher
Apr 01, 2025

Tenaya Slashes a Third of Workforce To Fund Development of Cardio Gene Therapies - BioSpace

Apr 01, 2025
pulisher
Mar 31, 2025

Tenaya to lay off about one-third of staff, reveals heart gene therapy data - Endpoints News

Mar 31, 2025

Finanzdaten der Tenaya Therapeutics Inc-Aktie (TNYA)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$1.08
price up icon 1.89%
$30.14
price down icon 3.74%
$573.26
price down icon 1.32%
$304.56
price up icon 3.98%
$4.50
price down icon 3.02%
$490.28
price down icon 19.01%
Kapitalisierung:     |  Volumen (24h):